标题
Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies
作者
关键词
-
出版物
Frontiers in Cell and Developmental Biology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-10-05
DOI
10.3389/fcell.2021.756315
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- In situ vaccination with nanoparticles for cancer immunotherapy: understanding the immunology
- (2021) Chenkai Mao et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?
- (2021) Laura Kate Gadanec et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation
- (2021) Mohamed M. Aboudounya et al. MEDIATORS OF INFLAMMATION
- TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target
- (2021) Gillina F. G. Bezemer et al. Frontiers in Pharmacology
- Pattern recognition receptor-initiated innate immune responses in mouse prostatic epithelial cells‡
- (2021) Xiaoqin Yu et al. BIOLOGY OF REPRODUCTION
- TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2
- (2021) Dhriti Kaushik et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Intracellular and Extracellular Lipopolysaccharide Signaling in Sepsis: Avenues for Novel Therapeutic Strategies
- (2021) Ramy S. Gabarin et al. Journal of Innate Immunity
- TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines
- (2021) Min Zheng et al. NATURE IMMUNOLOGY
- SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages
- (2021) Ioanna Pantazi et al. Frontiers in Immunology
- Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study
- (2020) Emmanuel Monnet et al. ANNALS OF THE RHEUMATIC DISEASES
- TAK-242, a specific inhibitor of Toll-like receptor 4 signalling, prevents endotoxemia-induced skeletal muscle wasting in mice
- (2020) Yuko Ono et al. Scientific Reports
- Toll-like receptor 7 contributes to neuropathic pain by activating NF-κB in primary sensory neurons
- (2020) Long He et al. BRAIN BEHAVIOR AND IMMUNITY
- Toll-like Receptors and the Control of Immunity
- (2020) Katherine A. Fitzgerald et al. CELL
- In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs
- (2020) Abhigyan Choudhury et al. JOURNAL OF MEDICAL VIROLOGY
- Talkin’ Toxins: From Coley’s to Modern Cancer Immunotherapy
- (2020) Robert D. Carlson et al. Toxins
- RNA Recognition and Immunity—Innate Immune Sensing and Its Posttranscriptional Regulation Mechanisms
- (2020) Takuya Uehata et al. Cells
- Vaccinia Virus Immunomodulator A46: Destructive Interactions with MAL and MyD88 Shown by Negative-Stain Electron Microscopy
- (2020) Daniel F. Azar et al. STRUCTURE
- When STING Meets Viruses: Sensing, Trafficking and Response
- (2020) Zhaohe Li et al. Frontiers in Immunology
- Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model
- (2020) Pamela C. Proud et al. EBioMedicine
- Innate immune-responses and their role in driving autoimmunity
- (2019) Elias Toubi et al. AUTOIMMUNITY REVIEWS
- The Still Underestimated Problem of Fungal Diseases Worldwide
- (2019) Fausto Almeida et al. Frontiers in Microbiology
- Role of self-organising myddosome oligomers in inflammatory signalling by Toll-like receptors
- (2019) Nicholas J. Gay BMC BIOLOGY
- Toll-Like Receptors, Infections, and Rheumatoid Arthritis
- (2019) Marina I. Arleevskaya et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
- (2019) Linda Hammerich et al. NATURE MEDICINE
- Management of psoriasis as a systemic disease: What is the evidence?
- (2019) N.J. Korman BRITISH JOURNAL OF DERMATOLOGY
- Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants
- (2019) Sudeep Kumar et al. Frontiers in Immunology
- Know Thyself: RIG-I-Like Receptor Sensing of DNA Virus Infection
- (2019) Yang Zhao et al. JOURNAL OF VIROLOGY
- Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms
- (2019) Maria K. Smatti et al. Viruses-Basel
- The heterogeneous nuclear ribonucleoprotein hnRNPM inhibits RNA virus-triggered innate immunity by antagonizing RNA sensing of RIG-I-like receptors
- (2019) Pan Cao et al. PLoS Pathogens
- What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion?
- (2019) Benedict C. Albensi Frontiers in Cell and Developmental Biology
- The endotoxin hypothesis of neurodegeneration
- (2019) Guy C. Brown Journal of Neuroinflammation
- Toll‐like receptors: The role in bladder cancer development, progression and immunotherapy
- (2019) Solmaz Ohadian Moghadam et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- The Role of TLRs in Anti-cancer Immunity and Tumor Rejection
- (2019) Zuzanna Urban-Wojciuk et al. Frontiers in Immunology
- STING signaling and host defense against microbial infection
- (2019) Jeonghyun Ahn et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Host Control of Fungal Infections: Lessons from Basic Studies and Human Cohorts
- (2018) Michail S. Lionakis et al. Annual Review of Immunology
- TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy
- (2018) Lan Huang et al. Cellular & Molecular Immunology
- Neurodegeneration in diabetic retinopathy: does it really matter?
- (2018) Rafael Simó et al. DIABETOLOGIA
- Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
- (2018) Kumar Vijay INTERNATIONAL IMMUNOPHARMACOLOGY
- Porphyromonas gingivalis lipopolysaccharide induces cognitive dysfunction, mediated by neuronal inflammation via activation of the TLR4 signaling pathway in C57BL/6 mice
- (2018) Jing Zhang et al. Journal of Neuroinflammation
- Targeting toll-like receptor-4 (TLR4)—an emerging therapeutic target for persistent pain states
- (2018) Kelly Bruno et al. PAIN
- Toll-Like Receptors, Associated Biological Roles, and Signaling Networks in Non-Mammals
- (2018) Li Nie et al. Frontiers in Immunology
- Comprehensive Long-Term Safety of Adalimumab from Eighteen Clinical Trials in Adult Patients With Moderate to Severe Plaque Psoriasis
- (2018) C. Leonardi et al. BRITISH JOURNAL OF DERMATOLOGY
- TLR4/MyD88 signaling determines the metastatic potential of breast cancer cells
- (2018) Kunlin Wu et al. Molecular Medicine Reports
- Targeting Toll-Like Receptors for Cancer Therapy
- (2018) Marc J. Braunstein et al. Targeted Oncology
- Strategies toward rheumatoid arthritis therapy; the old and the new
- (2018) Mojtaba Abbasi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- TLR8: No gain, no pain
- (2018) Franck J. Barrat JOURNAL OF EXPERIMENTAL MEDICINE
- Recent clinical trends in Toll-like receptor targeting therapeutics
- (2018) Muhammad Ayaz Anwar et al. MEDICINAL RESEARCH REVIEWS
- Immunopathogenesis of Rheumatoid Arthritis
- (2017) Gary S. Firestein et al. IMMUNITY
- Pathogenetic insights from the treatment of rheumatoid arthritis
- (2017) Iain B McInnes et al. LANCET
- Structural basis of TIR-domain-assembly formation in MAL- and MyD88-dependent TLR4 signaling
- (2017) Thomas Ve et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Therapeutic implications of toll-like receptors in peripheral neuropathic pain
- (2017) Krishan K. Thakur et al. PHARMACOLOGICAL RESEARCH
- M2000 (β-D-Mannuronic Acid) as a Novel Antagonist for Blocking the TLR2 and TLR4 Downstream Signalling Pathway
- (2017) S. Aletaha et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- TLR-Induced SMPD3 Defects Enhance Inflammatory Response of B Cell and Macrophage in the Pathogenesis of SLE
- (2017) F. Liu et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Structural basis of TIR-domain-assembly formation in MAL- and MyD88-dependent TLR4 signaling
- (2017) Thomas Ve et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation
- (2017) Chao-Yang Lai et al. Journal of Immunology Research
- Toll-like Receptor-Dependent Negative Effects of Opioids: A Battle between Analgesia and Hyperalgesia
- (2017) Masaud Shah et al. Frontiers in Immunology
- Toll-like receptors: promising therapeutic targets for inflammatory diseases
- (2016) Asma Achek et al. ARCHIVES OF PHARMACAL RESEARCH
- Therapeutic targeting of Toll-like receptors: a review of Toll-like receptors and their signaling pathways in psoriasis
- (2016) Farzaneh Rahmani et al. Expert Review of Clinical Immunology
- Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases—C3 or C5 emerge together with CD14 as promising targets
- (2016) Andreas Barratt-Due et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Application potential of toll-like receptors in cancer immunotherapy
- (2016) Ming Shi et al. MEDICINE
- Fusion of Enveloped Viruses in Endosomes
- (2016) Judith M. White et al. TRAFFIC
- The emerging role of Toll-like receptor 4 in myocardial inflammation
- (2016) Y Yang et al. Cell Death & Disease
- Blockade of Toll-Like Receptors (TLR2, TLR4) Attenuates Pain and Potentiates Buprenorphine Analgesia in a Rat Neuropathic Pain Model
- (2016) Agnieszka M. Jurga et al. NEURAL PLASTICITY
- The Use of IL-1 Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis: A Narrative Review
- (2016) Shankar Baskar et al. Cardiology Research and Practice
- Adalimumab: A Review in Chronic Plaque Psoriasis
- (2015) Celeste B. Burness et al. DRUGS
- Distinct single-cell signaling characteristics are conferred by the MyD88 and TRIF pathways during TLR4 activation
- (2015) Zhang Cheng et al. Science Signaling
- Human Cytomegalovirus miR-UL112-3p Targets TLR2 and Modulates the TLR2/IRAK1/NFκB Signaling Pathway
- (2015) Igor Landais et al. PLoS Pathogens
- Distinct single-cell signaling characteristics are conferred by the MyD88 and TRIF pathways during TLR4 activation
- (2015) Zhang Cheng et al. Science Signaling
- The inflammatory role of platelets via their TLRs and Siglec receptors
- (2015) Fabrice Cognasse Frontiers in Immunology
- Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling
- (2014) Agnieszka Płóciennikowska et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Novel drugs targeting Toll-like receptors for antiviral therapy
- (2014) Mira C Patel et al. Future Virology
- Inhibitors of TLR8 Reduce TNF Production from Human Rheumatoid Synovial Membrane Cultures
- (2014) S. M. Sacre et al. JOURNAL OF IMMUNOLOGY
- Recognition of LPS by TLR4: Potential for Anti-Inflammatory Therapies
- (2014) Reindert Nijland et al. Marine Drugs
- Chloroquine inhibits MGC803 gastric cancer cell migration via the Toll-like receptor 9/nuclear factor kappa B signaling pathway
- (2014) YANLI ZHANG et al. Molecular Medicine Reports
- TLR7 is a key regulator of innate immunity against Japanese encephalitis virus infection
- (2014) Arshed Nazmi et al. NEUROBIOLOGY OF DISEASE
- Adalimumab regulates intracellular TNFα production in patients with rheumatoid arthritis
- (2014) Carlos Zamora-Atenza et al. ARTHRITIS RESEARCH & THERAPY
- DNA Methylation in Mammals
- (2014) E. Li et al. Cold Spring Harbor Perspectives in Biology
- Toll-Like Receptor Signaling Pathways
- (2014) Takumi Kawasaki et al. Frontiers in Immunology
- Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies
- (2014) Maria Muccioli et al. Frontiers in Immunology
- Toll-like receptor 3 in viral pathogenesis: friend or foe?
- (2013) Renzo Perales-Linares et al. IMMUNOLOGY
- Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis
- (2013) Steven M. Opal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- TLR agonists: our best frenemy in cancer immunotherapy
- (2013) Sabina Kaczanowska et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Toll-Like Receptors in Antiviral Innate Immunity
- (2013) Sandra N. Lester et al. JOURNAL OF MOLECULAR BIOLOGY
- Toll-like receptors in urothelial cells—targets for cancer immunotherapy
- (2013) Hélène LaRue et al. Nature Reviews Urology
- The Yin and Yang of Toll-like receptors in cancer
- (2013) J-P Pradere et al. ONCOGENE
- Targeting Toll-Like Receptors: Promising Therapeutic Strategies for the Management of Sepsis-Associated Pathology and Infectious Diseases
- (2013) Athina Savva et al. Frontiers in Immunology
- Staphylococcus aureus Induces Type I IFN Signaling in Dendritic Cells Via TLR9
- (2012) D. Parker et al. JOURNAL OF IMMUNOLOGY
- Fungal pathogens—a sweet and sour treat for toll-like receptors
- (2012) Christelle Bourgeois et al. Frontiers in Cellular and Infection Microbiology
- The Role of TLR2 in Infection and Immunity
- (2012) Laura Oliveira-Nascimento et al. Frontiers in Immunology
- The Long-Term Safety of Adalimumab Treatment in Moderate to Severe Psoriasis
- (2011) Craig Leonardi et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Innate immunity in the pathogenesis of psoriasis
- (2011) Cheryl M. Sweeney et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
- (2011) Taro Kawai et al. IMMUNITY
- Targeting of Toll-like receptors: a decade of progress in combating infectious diseases
- (2011) Mona Hedayat et al. LANCET INFECTIOUS DISEASES
- Toll-Like Receptor 4 Is Involved in Inflammatory and Joint Destructive Pathways in Collagen-Induced Arthritis in DBA1J Mice
- (2011) Matthias Pierer et al. PLoS One
- Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis
- (2011) F. G. Goh et al. RHEUMATOLOGY
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- The global burden of bacterial and viral zoonotic infections
- (2010) L. Christou CLINICAL MICROBIOLOGY AND INFECTION
- Localisation and trafficking of Toll-like receptors: an important mode of regulation
- (2010) Anne F McGettrick et al. CURRENT OPINION IN IMMUNOLOGY
- Is ustekinumab superior to etanercept for psoriasis?
- (2010) Annegret Kuhn et al. Nature Reviews Rheumatology
- CpG Oligodeoxyneucleotides as TLR9 Agonists
- (2009) Yanal M. Murad et al. BIODRUGS
- The roles of TLRs, RLRs and NLRs in pathogen recognition
- (2009) T. Kawai et al. INTERNATIONAL IMMUNOLOGY
- TLRs and chronic inflammation
- (2009) Caroline Ospelt et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer
- (2009) M Szajnik et al. ONCOGENE
- The IKK Complex, a Central Regulator of NF- B Activation
- (2009) A. Israel Cold Spring Harbor Perspectives in Biology
- Toll-like receptors regulation of viral infection and disease☆
- (2008) J THOMPSON et al. ADVANCED DRUG DELIVERY REVIEWS
- Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: Toll-like receptor expression in early and longstanding arthritis
- (2008) Caroline Ospelt et al. ARTHRITIS AND RHEUMATISM
- Role of TLR9 in hepatic stellate cells and experimental liver fibrosis
- (2008) Erwin Gäbele et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cancers take their Toll—the function and regulation of Toll-like receptors in cancer cells
- (2008) R Chen et al. ONCOGENE
- TLR signaling by tumor and immune cells: a double-edged sword
- (2008) B Huang et al. ONCOGENE
- TLR7 and TLR8 as targets in cancer therapy
- (2008) M P Schön et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now